Affordable Access

Melatonin Regulates Angiogenic Factors Under Hypoxia in Breast Cancer Cell Lines

Authors
  • Jardim-Perassi, Bruna Victorasso
  • Lourenco, Mateus Repoles
  • Doho, Gabriel Mandarini
  • Grigolo, Ingrid Helen
  • Gelaleti, Gabriela Bottaro
  • Ferreira, Livia Carvalho
  • Borin, Thaiz Ferraz
  • Moschetta, Marina Gobbe
  • Pires de Campos Zuccari, Debora Aparecid...
Publication Date
Jan 01, 2016
Source
Repositório Institucional UNESP
Keywords
Language
English
License
Unknown
External links

Abstract

Angiogenesis is the process of new blood vessel formation, regulated by a number of pro-and anti-angiogenic factors and usually begins in response to hypoxia. Exogenous administration of melatonin has shown numerous anti-tumor effects and appears to inhibit tumor angiogenesis. However, many factors involved in the anti-angiogenic effect of melatonin are still under investigation. Here, we evaluate the effects of melatonin on cell viability and expression of angiogenic factors in MCF-7 and MDA-MB-231 breast cancer cells under hypoxic conditions. Cell viability was investigated by MTT and gene and protein expression of the hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF-A) were verified by qPCR and immunocytochemistry after melatonin treatment (1 mM) under hypoxic conditions. Additionally, a protein array with 20 different cytokines/factors was performed on tumor cell lysates. The results showed that 1 mM of melatonin reduced the viability of MCF-7 and MDA-MB-231 cells (p < .05). This treatment also decreased both gene and protein expression of HIF-1a and VEGF-A under hypoxic conditions (p < .05). Among the proteins evaluated by protein array, melatonin treatment during hypoxia reduced VEGF-C, VEGFR receptors (VEGFR2 and VEGFR3), matrix metalloproteinase 9 (MMP9) and Angiogenin in MCF-7 cells. In MDA-MB-231 cells, a significant decrease was observed in VEGFR2, epidermal growth factor receptor (EGFR) and Angiogenin (p < .05). Taken together, these results showed that melatonin acts in the regulation of angiogenic factors in breast tumor cells and suggests an anti-angiogenic activity, particularly under hypoxic conditions.

Report this publication

Statistics

Seen <100 times